Graft-versus-host disease

Area of Science:

• Immunology
• Hematology
• Transplantation Science

Background:

• Allogeneic haematopoietic stem-cell transplantation (SCT) is a vital curative treatment for hematological malignancies and inherited blood disorders.
• Donor T cells in SCT grafts restore immunity and fight cancer but can cause graft-versus-host disease (GVHD) by attacking the recipient.
• Minimizing GVHD while retaining anti-leukemic effects is crucial for realizing the full potential of SCT.

Purpose of the Study:

• To review research in mouse models focused on developing strategies to mitigate GVHD after allogeneic SCT.
• To explore methods for preserving the graft-versus-leukemia effect of donor T cells during SCT.

Main Methods:

• Review of preclinical studies utilizing mouse models of allogeneic SCT.
• Analysis of experimental approaches targeting T-cell mediated immune responses in transplantation.

Main Results:

• Mouse models provide insights into the mechanisms underlying GVHD.
• Various strategies are being investigated to selectively inhibit GVHD-inducing T cells or promote regulatory T-cell function.
• Preclinical data guides the development of safer SCT protocols.

Conclusions:

• Further research in mouse models is essential for developing effective GVHD management strategies.
• Achieving a balance between GVHD suppression and graft-versus-leukemia activity is key to improving SCT efficacy.
• Translating findings from mouse models to clinical practice holds promise for enhancing SCT outcomes.